Vivozon Holdings Large Shareholding Report Amendment: Reporting Obligation Date Corrected, No Change in Holdings or Pledge Structures


  • Vivozon Holdings amended its large shareholding report, correcting the reporting obligation date from June 19, 2026 to June 23, 2026.
  • This correction is a simple clerical error fix; all figures including the 19,787,259 shares 31.72% stake and 10,513,471 shares 16.85% under major contracts remain unchanged.
  • The previously disclosed pledge of 4.5 million shares to SangSangIn Savings Bank and the collateral release from early redemption of exchangeable bonds are unaffected, with no new financial impact.
  • [AI Summary]This amendment is a purely procedural date correction providing no new information to investors. While the existing high-interest borrowing and pledge arrangements remain relevant, this disclosure itself has a neutral impact on the stock price.

KOSDAQ Filing Information


  • [Correction of Description] Report on Large Shareholdings (General)
  • Company: Vivozon Pharmaceutical (082800)
  • Submission: Vivozon Holdings

  • Shares: 60,719,666
  • Price: 2,670 KRW
  • Market Cap: 162.1 B KRW